Vesilute 20mg

Vesilute is a short peptide bioregulator developed to target the tissues of the bladder and urinary tract. Peptide bioregulators of this class are short-chain amino acid sequences that interact with specific cell receptors to support normal gene expression and cellular homeostasis within targeted tissue types. Research into bioregulator peptides suggests they may influence the regulation of cellular function in organ-specific tissues, making them a subject of growing interest in gerontological and urological research fields.

In laboratory settings, Vesilute has been investigated for its potential role in supporting bladder epithelial cell function and urinary tract tissue integrity. Its mechanism of action is understood to involve binding to chromatin structures within target cells, potentially modulating protein synthesis at a genetic level — consistent with the broader class of cytomedine-derived peptide bioregulators.

Each 20mg vial of Vesilute is supplied as a lyophilised powder, ensuring stability during storage and transport. Recommended storage is at -20°C, protected from light and moisture, with a shelf life consistent with standard lyophilised peptide preparations. Purity is confirmed at >98% via HPLC analysis.

For research purposes only. Not for human use. This product is intended solely for in vitro and preclinical research applications by qualified professionals.